Pharmaceutical Market Europe • February 2025 • 5
CONTENTS
NEWS & COLUMNS
6-7 NEWS
J&J to acquire Intra-Cellular for $14.6bn; Biogen/Eisai’s Alzheimer’s drug approved by FDA
8-9 NEWS
Pfizer's sasanlimab shows promise in bladder cancer; WHO urges US to ‘reconsider’ withdrawal
10-11 DERMATOLOGY NEWS
Gilead and LEO enter $1.7bn inflammation deal; New collaboration to treat epidermolysis bullosa
12 DARWIN'S MEDICINE
Astrategia – strategy blindness is a thing
13 WHAT IS IT ALL FOR?
The role of healthcare comms in the fight
to help improve health and wellness
14 INNOVATIVE IMPACT
The full potential of patient journeys in pharma
15 HEALTHCARE COMMS
Using impact to show accountability
FEATURES
16-17 WHY LOCAL KNOWLEDGE IS KEY TO GLOBAL PHARMACOVIGILANCE OUTCOMES
The challenge for companies is to ensure their local affiliates meet local PV obligations while staying aligned with global PV requirements
20-21 KEY CLINICAL TRIAL TRENDS
– EU VS US PERSPECTIVES
Highlighting the distinct priorities
and hurdles faced by sponsors, CROs
and sites around the world
22-23 RARE DISEASE DAY
Looking at the latest news and developments in the rare disease area: MHRA approves Italfarmaco’s Duvyzat for DMD; Biogen’s SMA regimen accepted for EMA/FDA review; Eli Lilly and Alchemab enter ALS partnership; FDA approves SpringWorks’ Gomekli for neurofibromatosis type 1; Novo Nordisk’s haemophilia A therapy shows promise in phase 3 trial
COMMUNIQUE
MARKETING & COMMS
26-28 INCLUSIVITY, COLLABORATION AND TARGETED CARE
The challenge of achieving inclusivity for ethnic minorities and women in clinical trials
30-32 MARKETING OBJECTIVES – SETTING YOUR SIGHTS
Strong brands need clear objectives – the four steps to avoiding wombat marketing
33-35 PREPARING BIOTECHS
FOR SPIN-OUT AND BEYOND
Part 1 of this article looked at the formation of biotechnology spin-outs from a broad economic perspective and the impact of the recent budget. Now we will consider the process in more detail from the spin-outs’ perspective
39 HEALTHCARE COMMS
Havas Health Network launches
Havas Life London; UK healthcare
agency twentyeightc launches
CAREERS & RECRUITMENT
36-38 APPOINTMENTS
Changes at Biogen, LEO and Vortex Biotech
40 PHARMA MARKETING JOBS
Visit our new website for all your recruiting needs!